Aktiesnakken — August 2010
-
Spørgsmålet er om man tør sælge.. 67,40/ 67,70
-
Tak for din indsats i Genmab igår aka, den overbeviste mig om at det er her de virkelig banebrydende analyse-ting sker.
-
Rth jeg har ikke læst det, men det må anses for skuffende, men det skal dog tillægges arzerra. Men grundlæggende er det jo godt med det mindre burn
-
Tak for det
-
Nøglen ligger i likviditet som jo er de 2 mia med fabrikken
-
Den ramte jeg da lige i r.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind